Whose Genes Anyway?: Congressional action on Section 101 of US patent law could reopen path to patenting genes Clinical OMICs News
In early-to-mid June, the Intellectual Property Subcommittee of the U.S. Senate Judiciary Committee held three days of hearings on proposed legislation to …